{"id":"https://openalex.org/W1671402800","doi":null,"title":"Chronic myeloid leukemia: diagnosis and treatment","display_name":"Chronic myeloid leukemia: diagnosis and treatment","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W1671402800","mag":"1671402800"},"language":"en","primary_location":{"id":"mag:1671402800","doi":null,"is_oa":true,"landing_page_url":"https://dialnet.unirioja.es/descarga/articulo/3621217.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210180566","display_name":"CES Medicina","issn_l":"2215-9177","issn":["2215-9177","0120-8705"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210128920","host_organization_name":"Universidad CES","host_organization_lineage":["https://openalex.org/I4210128920"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"CES Medicina","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://dialnet.unirioja.es/descarga/articulo/3621217.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004456297","display_name":"Catalina Morales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128920","display_name":"Universidad CES","ror":"https://ror.org/037p13h95","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210128920"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Catalina Morales","raw_affiliation_strings":["Universidad CES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad CES","institution_ids":["https://openalex.org/I4210128920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051427107","display_name":"V\u00edctor Torres C\u00e1rdenas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128920","display_name":"Universidad CES","ror":"https://ror.org/037p13h95","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210128920"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"V\u00edctor Torres C\u00e1rdenas","raw_affiliation_strings":["Universidad CES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad CES","institution_ids":["https://openalex.org/I4210128920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086891150","display_name":"Juan Esteban Valencia Z","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Esteban Valencia Z","raw_affiliation_strings":["Laboratorio Bristol Myers Squibb"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio Bristol Myers Squibb","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070494544","display_name":"Gabriel Rib\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Rib\u00f3n","raw_affiliation_strings":["Laboratorio Bristol Myers Squibb"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio Bristol Myers Squibb","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057937750","display_name":"Rub\u00e9n Dar\u00edo Manrique H","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128920","display_name":"Universidad CES","ror":"https://ror.org/037p13h95","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210128920"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Rub\u00e9n Dar\u00edo Manrique H","raw_affiliation_strings":["Universidad CES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad CES","institution_ids":["https://openalex.org/I4210128920"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1769,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.79386358,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"24","issue":"1","first_page":"97","last_page":"108"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.9819999933242798},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/disease-phases","display_name":"disease phases","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7933636903762817},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.6600313782691956},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6518331170082092},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5689451694488525},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5108206272125244},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.4716479182243347},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4622255563735962},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.454969197511673},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.45284923911094666},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4437035322189331},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44228336215019226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4143192768096924},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.41240790486335754},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3770056366920471},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36266717314720154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3467240333557129},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1934359073638916},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1510981321334839},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1347917914390564},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.11405041813850403},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07748067378997803}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1671402800","doi":null,"is_oa":true,"landing_page_url":"https://dialnet.unirioja.es/descarga/articulo/3621217.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210180566","display_name":"CES Medicina","issn_l":"2215-9177","issn":["2215-9177","0120-8705"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210128920","host_organization_name":"Universidad CES","host_organization_lineage":["https://openalex.org/I4210128920"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"CES Medicina","raw_type":null}],"best_oa_location":{"id":"mag:1671402800","doi":null,"is_oa":true,"landing_page_url":"https://dialnet.unirioja.es/descarga/articulo/3621217.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210180566","display_name":"CES Medicina","issn_l":"2215-9177","issn":["2215-9177","0120-8705"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210128920","host_organization_name":"Universidad CES","host_organization_lineage":["https://openalex.org/I4210128920"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"CES Medicina","raw_type":null},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W316422158","https://openalex.org/W1975410130","https://openalex.org/W1976244025","https://openalex.org/W1981111174","https://openalex.org/W1984313504","https://openalex.org/W1986058924","https://openalex.org/W1994309500","https://openalex.org/W2023117511","https://openalex.org/W2024021544","https://openalex.org/W2027613124","https://openalex.org/W2031658816","https://openalex.org/W2032938895","https://openalex.org/W2039045990","https://openalex.org/W2057508802","https://openalex.org/W2058677025","https://openalex.org/W2060848548","https://openalex.org/W2064016607","https://openalex.org/W2064831267","https://openalex.org/W2082580993","https://openalex.org/W2084199623","https://openalex.org/W2093017212","https://openalex.org/W2100500978","https://openalex.org/W2103796073","https://openalex.org/W2114266850","https://openalex.org/W2121990442","https://openalex.org/W2126235458","https://openalex.org/W2134566943","https://openalex.org/W2152648806","https://openalex.org/W2164452916","https://openalex.org/W2184408086","https://openalex.org/W2312804644"],"related_works":["https://openalex.org/W4408538325","https://openalex.org/W4414257351","https://openalex.org/W2066447958","https://openalex.org/W2976822296","https://openalex.org/W2154748255","https://openalex.org/W4390477630","https://openalex.org/W2060745527","https://openalex.org/W2105763112","https://openalex.org/W1553637433","https://openalex.org/W2625953301"],"abstract_inverted_index":{"The":[0,167,189,228],"American":[1],"Cancer":[2],"Society":[3],"estimates":[4],"that":[5,256,258],"5.050":[6],"new":[7],"cases":[8,83],"of":[9,30,64,68,73,79,91,105,201,213,230,238,247,253,264,288],"chronic":[10,31,96,215],"myeloid":[11,32,97,216],"leukemia":[12,33,69,98,217],"(CML)":[13],"were":[14],"diagnosed":[15,94],"in":[16,19,24,34,160],"United":[17,26],"States":[18,27],"2009.":[20],"About":[21],"470":[22],"persons":[23],"the":[25,92,103,106,136,161,165,202,211,214,221,234,239,245,248,254,265,278,283,289],"will":[28,99,109,205,272],"die":[29],"2009,":[35],"with":[36,51,58,76,95],"an":[37,77,141,149],"age":[38],"range":[39],"going":[40],"from":[41,47],"45":[42],"to":[43,49,61,81,120,131,155,187,233,262,267,296],"55,":[44,50],"a":[45,59,111,132,179,286],"mean":[46],"53":[48],"less":[52,114],"than":[53,89,115],"10%":[54],"under":[55],"20":[56,261],"years,":[57],"male":[60],"female":[62],"proportion":[63],"1,4:1.":[65],"This":[66,146],"kind":[67],"represents":[70],"between":[71],"15-20%":[72],"all":[74],"leukemias,":[75],"incidence":[78],"1":[80],"2":[82],"per":[84],"each":[85],"100,000":[86],"adults.":[87,122],"More":[88],"50%":[90],"patients":[93,204,266],"be":[100],"asymptomatic":[101],"at":[102,210],"time":[104,212],"diagnosis":[107],"and":[108,127,158,174,185,192,199,250],"have":[110,206],"life":[112],"expectancy":[113],"39%":[116],"if":[117],"they":[118],"compared":[119],"healthy":[121],"CML":[123,290],"affects":[124],"adults":[125],"principally":[126],"it":[128],"is":[129,220,270,277,292],"associated":[130],"chromosomal":[133],"abnormality":[134],"called":[135,144,152],"Philadelphia":[137],"Chromosome,":[138],"which":[139,291],"generates":[140],"abnormal":[142,150],"gene":[143,147],"BCR-ABL.":[145],"produces":[148],"protein":[151],"Tyrosine-Kinase,":[153],"believed":[154],"cause":[156],"growth":[157,249],"development":[159],"cells":[162,255],"affected":[163],"by":[164,282],"leukemia.":[166],"disease":[168],"has":[169,178],"3":[170],"phases:":[171],"chronic,":[172],"accelerated":[173,190],"blastic.":[175],"Each":[176],"phase":[177,191,194],"different":[180],"duration":[181],"time,":[182],"clinical":[183],"presentation":[184],"response":[186],"treatment.":[188],"blastic":[193],"are":[195],"considered":[196],"advanced":[197],"phases,":[198],"15%":[200],"total":[203],"reached":[207],"those":[208],"phases":[209],"diagnosis.":[218],"Imanitib":[219],"first":[222,279],"multiple":[223],"synthetic":[224],"Tyrosine":[225],"Kinase":[226,242],"inhibitor.":[227],"union":[229],"this":[231],"medication":[232],"ATP":[235],"binding":[236],"sites":[237],"inactive":[240],"BCR-ABL":[241],"conformation":[243],"achieves":[244],"inhibition":[246],"induces":[251],"apoptosis":[252],"express":[257],"conformation.":[259],"Approximately":[260],"30%":[263],"whom":[268],"Imatinib":[269],"administered":[271],"develop":[273],"resistance.":[274],"Dasatinib":[275],"(BMS-354825)":[276],"therapy":[280],"authorized":[281],"FDA":[284],"as":[285],"treatment":[287],"resistant":[293],"or":[294],"intolerant":[295],"Imatinib.":[297]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}